A non‐randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady‐state pharmacokinetics of lamotrigine in patients with bipolar I disorder
1. Bristol‐Myers Squibb, Princeton, New Jersey, USA;2. Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, Maryland, USA;3. Bristol‐Myers Squibb, Plainsboro, New Jersey, USA